Quality and utility of [(123)I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator

OBJECTIVE: Impaired cardiac adrenergic activity has been demonstrated in heart failure (HF) and in diabetes mellitus (DM). [(123)I]I-metaiodobenzylguanidine (MIBG) enables assessment of the cardiac adrenergic nervous system. Tomographic imaging of the heart is expected to be superior to planar imagi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Nucl Med
Autori principali: Teresińska, Anna, Woźniak, Olgierd, Maciąg, Aleksander, Wnuk, Jacek, Jezierski, Jarosław, Fronczak, Aneta, Biernacka, Elżbieta Katarzyna
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Singapore 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285320/
https://ncbi.nlm.nih.gov/pubmed/34023989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12149-021-01628-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi